Rahul Narang
Datos Biográficos
| ID | 9064254 |
|---|---|
| NOMBRE | Rahul Narang |
| NOMBRES | Rahul |
| APELLIDO | Narang |
| FIRMA | NARANG R |
| AFILIACIONES | All India Institute of Medical Sciences |
| ORCID | 0000-0001-9973-5311 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 1 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 1 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2023 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2023 |
| ÍNDICE H | 0 |
Vaccination coverage and breakthrough infections of Covid-19 during the second wave among staff of selected medical institutions in India
India experienced the second wave of SARS-CoV-2 infection from April 3 to June 10, 2021. During the second wave, Delta variant B.1617.2 emerged as the predominant strain, spiking cases from 12.5 million to 29.3 million (cumulative) by the end of the surge in India. Vaccines against COVID-19 are a potent tool to control and end the pandemic in addition to other control measures. India rolled out its vaccination programme on January 16, 2021, initi…
Sin obras prominentes en esta página.
Vaccination coverage and breakthrough infections of Covid-19 during the second wave among staff of selected medical institutions in India
India experienced the second wave of SARS-CoV-2 infection from April 3 to June 10, 2021. During the second wave, Delta variant B.1617.2 emerged as the predominant strain, spiking cases from 12.5 million to 29.3 million (cumulative) by the end of the surge in India. Vaccines against COVID-19 are a potent tool to control and end the pandemic in addition to other control measures. India rolled out its vaccination programme on January 16, 2021, initi…
COVID-19 epidemiological studies (1 obras) · Disease (1 obras) · Emergency Medicine (1 obras) · Family medicine (1 obras) · Infection control (1 obras) · Intensive care medicine (1 obras) · Internal Medicine (1 obras) · Medicine (1 obras) · Pandemic (1 obras) · Pediatrics (1 obras)